- Country: Peru
- Summary: Acquisition of Pharmaceutical Product Risperidone 25 Mg Injectable by Single Supplier for Iafas-Ep Beneficiaries
- PET Ref No: 101648152
- Deadline: 03 Jun 2024
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: PEN 750350.00
- Notice Type: Tender
- Document Ref. No.: DIRECTA-PROC-13-2024-IAFAS-EP-1
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Acquisition of Pharmaceutical Product Risperidone 25 Mg Injectable by Single Supplier for Beneficiaries of the Iafas-Ep
Object of Contract: Good
Description of the Object: ACQUISITION OF PHARMACEUTICAL PRODUCT RISPERI...
Estimated Value / Reference Value750,350.00 Soles
Amount of the Right of Disclaimer : Submission date not Mention in this Notice so we can assumed date - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINAcquisition of Pharmaceutical Product Risperidone 25 Mg Injectable by Single Supplier for Iafas-Ep Beneficiaries - Peru Tender
The IAFAS OF THE PERU ARMY (FOSPEME), a Government sector organization in Peru, has announced a new tender for Acquisition of Pharmaceutical Product Risperidone 25 Mg Injectable by Single Supplier for Iafas-Ep Beneficiaries. This tender is published on PeruTenders under PET Ref No: 101648152 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-06-03.
The estimated tender value is PEN 750350.00, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
